AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06314100 — intervention group
Intervention type: BEHAVIORAL
Intervention: cigarette smoking
Description: The study aims to explore the effect of cigarette smoking on microbiome of the supragingival dental biofilm and the risk of developing caries lesions
Study NCT06314100 — intervention group
Intervention type: BEHAVIORAL
Intervention: non smoking
Description: The non smoking group of subjects serve as control for the other two groups
Study NCT06117423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adalimumab-680LT
Description: First, adalimumab-680LT was administered intravenously. 2-3 days later, a Fluorescence Molecular Imaging procedure was performed to enable the visualisation and detection of fluorescence signals.
Study NCT06117423 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Fluorescence Molecular Imaging was performed to enable the visualisation and detection of fluorescence signals.
Study NCT04962997 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Investigator will ensure the completion of a hetero-administered questionnaire which will be carried out in French, English, Portuguese or Spanish depending on the language spoken by the participant, including informations related to Demography and socio-economic conditions, Addictions, Work and studies, Housing, Health coverage, Gender and sexuality, Vulnerabilities and violence, Recourse to care, State of physical health, Mental Health, Prevention and Sexually Transmitted Infections (STIs), Checkup, Transition path and clinical complications and Dermatological problems.~Investigator will collect the data relating to the clinical examination, dermatological examination and the search for STIs (blood and / or urine) carried out in the routine care of the participant in a case report form (CRF).~The estimated duration of the interviews and the consultation is approximately 1 hour and 30 minutes per patient.
Study NCT05446753 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Animal-based meats
Description: Animal-based meats from beef, pork and chicken
Study NCT05446753 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant-based meat alternatives
Description: Plant-based meat alternatives of beef, pork and chicken
Study NCT05775172 — intervention group
Intervention type: PROCEDURE
Intervention: Sleeve gastrectomy
Description: laparoscopic sleeve gastrectomy was done under general anesthesia by the same surgeon in the SBAHC. Routine preoperative, and postoperative care (including early post-operative dietary management) were done. Baseline assessment was taken within the last week before the surgery during the preoperative preparation and the final assessment was recorded 6 months after the surgery date.
Study NCT05775172 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Lifestyle intervention
Description: balanced 500 to 1000-calorie-deficit diet, personalized physical activity plan, and customized behavioral modification
Study NCT05775172 — intervention group
Intervention type: OTHER
Intervention: Control
Description: No interventions were applied
Study NCT05304234 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound or abbreviated MRI
Description: Abdominal ultrasound or abbreviated MRI
Study NCT05118997 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IRRAflow
Description: IRRAflow consists of a control unit and disposables (dual-lumen catheter and tube set) to offer an integrated and synchronized active fluid exchange system. Active fluid exchange is the combination of traditional gravity-driven drainage with periodic, controlled irrigation of the catheter probe to exchange any pathological fluid collection with neutral physiological fluids.
Study NCT05118997 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EVD
Description: An external ventricular drain (EVD), also known as a ventriculostomy or extraventricular drain, is a device used in neurosurgery to treat hydrocephalus and relieve elevated intracranial pressure when the normal flow of cerebrospinal fluid inside the brain is obstructed.
Study NCT05630443 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: prone position
Description: Ordinary ERAS treatment postoperatvely adding the prone position and voicetraining
Study NCT05449405 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Chlorpheniramine Maleate 1% Nasal Spray
Description: Chlorpheniramine Maleate 1% Nasal Spray
Study NCT05449405 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo nasal spray
Study NCT06336317 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Influenza vaccine
Description: VaxigripTetra Suspension for injection, 0,5ml prefilled syringe ATC code: J07BB02
Study NCT06336317 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sodium Chloride Solution for infusion, 9mg/ml ATC code: B05BB01
Study NCT05495308 — intervention group
Intervention type: PROCEDURE
Intervention: neoadjuvant treatment
Description: We study the number of patients who achive a complete pathological response after neoadjuvant treatment with radiochemotherapy.
Study NCT05548972 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: G7 Dual Mobility with Vivacit-E bearing
Description: hip arthroplasty with G7 Dual Mobility Vivacit-E bearing
Study NCT05548972 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: G7 Dual Mobility Longevity bearing
Description: hip arthroplasty with G7 Dual Mobility Longevity bearing
Study NCT05223010 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin 5 MG/15 ML Oral Solution 0.05 mg/kg
Description: will be administered 1 hour before arrival to operating room
Study NCT05223010 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin 5 MG/15 ML Oral Solution 0.2mg/kg
Description: will be administered 1 hour before arrival to operating room
Study NCT05223010 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin 5 MG/15 ML Oral Solution 0.4mg/kg
Description: will be administered 1 hour before arrival to operating room
Study NCT05223010 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: for anaesthesia induction 3-8 MAC
Study NCT05433649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise
Description: The therapeutic exercise intervention with the help of elastic bands was carried out for 8 weeks with a frequency of two sessions per week, for a total of 16 sessions of 45 minutes duration.
Study NCT05071586 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Soterix 1x1 tDCS LTE Stimulator Device Model 1401
Description: Participants will receive 20 minutes of 1.5 mA (Milliampere) transcranial direct current stimulation (tDCS) via Soterix 1x1 tDCS LTE Stimulator Device Model 1401 with a bilateral M1 montage.
Study NCT06080542 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Aerobic
Description: This session will consist of an aerobic training session performed on a cycle ergometer.
Study NCT06080542 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Description: This session will consist of a HIIT performed with elastic bands
Study NCT06161714 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Articaine 4%/Epi 1:100000 Inj Cart 1.7Ml
Description: 4% articaine with 1:100,000 epinephrine buccal infiltration
Study NCT06161714 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine 2%/Epi 1:100000 Inj Cart 1.7Ml
Description: 2% Lidocaine with 1:100,000 epinephrine buccal infiltration
Study NCT01013714 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac Sympathetic Denervation (CSD)
Description: Cardiac sympathetic denervation is performed using an endoscopic procedure called VATS (video-assisted thoracoscopic sympathectomy). The surgeon removes the lower half of the stellate ganglia in addition to the thoracic ganglia of T2 - T4 on both the right and left side. The VATS procedure provides a minimally invasive endoscopic approach that is safe and effective. The procedure can be completed in less than 45 minutes on each side.
Study NCT01013714 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Routine Care
Description: Anti-arrhythmic medications are continued for the duration of the study unless discontinued or adjusted to due to drug toxicity, intolerance, or ICD shock. All anti-arrhythmic medications (whether in the routine care or surgical arm) can be adjusted at the discretion of the treating physician.
Study NCT01013714 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Routine Care
Description: Anti-arrhythmic medications are continued for the duration of the study unless discontinued or adjusted to due to drug toxicity, intolerance, or ICD shock. All anti-arrhythmic medications (whether in the routine care or surgical arm) can be adjusted at the discretion of the treating physician.
Study NCT04754646 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Split-face injection of RHA® 4 with a cannula into a single NLF.
Description: RHA® 4 is a sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus equi bacteria, formulated to a concentration of 23 mg/mL and 0.3% w/w lidocaine in a physiologic buffer.~Up to 3.0 mL injected per NLF (mid-dermis to deep-dermis). Touch-up treatment provided at 2 weeks (up to 3.0 mL per NLF).~The brand of cannula used for injection is up to the discretion of the Treating Investigator (TI), providing the cannula is registered for use by the US FDA.
Study NCT04754646 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Split-face injection of RHA® 4 with a needle (TSK 27G x ½) into the contralateral NLF.
Description: RHA® 4 is a sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus equi bacteria, formulated to a concentration of 23 mg/mL and 0.3% w/w lidocaine in a physiologic buffer.~Up to 3.0 mL injected per NLF (mid-dermis to deep-dermis). Touch-up treatment provided at 2 weeks (up to 3.0 mL per NLF).
Study NCT06520527 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Andrographis paniculata
Description: Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
Study NCT06520527 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brisk Walking Exercise
Description: Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.
Study NCT06520527 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combination
Description: Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.~Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
Study NCT05204914 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Supra glottic airway devices
Description: Using the device in save air way in patients under general anesthesia and the change in the tempromandibular joint will be evaluated
Study NCT05631938 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytisinicline
Description: film-coated oral tablets containing 3 mg cytisinicline
Study NCT04745741 — intervention group
Intervention type: RADIATION
Intervention: IB-positive group
Description: The gross tumor volume of the nasopharynx and neck nodes (GTVnx and GTVnd) were delineated according to the tumor extension. The CTVnx was defined as GTVnx + nasopharynx mucosa + 8mm +corresponding anatomical structure without the delineation of CTV1. The CTVnd was defined as GTVnd plus the elective neck area. The prescribe doses of GTVnx/GTVnd, CTVnx, CTVnd were 66-70Gy,54-56Gy and 50-54Gy in 31-35 fractions, respectively.
Study NCT05361967 — intervention group
Intervention type: DEVICE
Intervention: The Tack Endovascular System
Description: The Tack Endovascular System is designed to treat vascular dissections with Tack implant(s) following angioplasty.
Study NCT06132334 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Upper extremity aerobic exercise training
Description: Aerobic exercise training will be given to the training group on an arm ergometer 3 days in a week and 30-45 minutes a day for 6 weeks with the assistance of a physiotherapist. The training workload of aerobic exercise training will be applied at 50-80% of peak oxygen consumption or 60-80% of peak heart rate, dyspnea 3-4 points according to the Modified Borg Scale (MBS) or fatigue 4-6 points.~Blood sugar measurement will be performed before exercise training. Individuals with a blood sugar result of >300 mg/dL will not be allowed to exercise that day.
Study NCT06132334 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control Group
Description: The control group will not be given any training during the 6-week period. After the study, the treatment applied to the training group will also be applied to the control group in order to ensure that the patients in the control group are not ethically deprived of rehabilitation.
Study NCT05515133 — intervention group
Intervention type: OTHER
Intervention: stressors
Description: Patients are exposed to stressful situations related to the diagnosis and treatment of the disease
Study NCT05544591 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 611 Q2W
Description: subcutaneous injection, 600mg (loading dose, week 0) + 300mg Q2W (maintenance dose, from Week 2 to Week 14, 7 cycles)
Study NCT05544591 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 611 Q4W
Description: subcutaneous injection, 600mg (loading dose, Day1) + 300mg Q4W (maintenance dose, on week 4, 8, 12) + placebo Q4W (on week 2, 6, 10, 14)
Study NCT05544591 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching placebo
Description: subcutaneous injection, Q2W, from Week 2 to Week 14, 7 cycles
Study NCT06251271 — intervention group
Intervention type: DEVICE
Intervention: Point-of-Care Ultrasound
Description: Patients will undergo routine point-of-care ultrasound scans as part of the diagnostic process. The collected sonographic data and PFT results will assess point-of-care ultrasound's accuracy in diagnosing OLDs within the natural clinical setting.
Study NCT01512316 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: d-Cycloserine
Description: 250mg, one dose, 2hrs prior to fMRI
Study NCT05837091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Sodium Oxybate
Description: Titrated according to standard of care and continued on stable dose for 3 months
Study NCT05837091 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 24-hour polysomnography
Description: Performed in a sleep study lab, recording of body functions including brain activity, eye movements, muscle activity, heart rhythm and blood oxygen levels while asleep and awake for a 24-hour period
Study NCT05837091 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nextsense EEG earbuds
Description: Ear buds used to record sleep staging worn for a 24-hours period
Study NCT05837091 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Axivity device
Description: Wristband that records activity level worn for approximately one month to track sleep and steps/activity.
Study NCT01512316 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lactose pill
Description: one dose, 2hrs prior to fmri
Study NCT01512316 — intervention group
Intervention type: GENETIC
Group type: PLACEBO_COMPARATOR
Intervention: Saliva sample
Description: Buccal cell material will be sampled from all participants on day3
Study NCT01512316 — intervention group
Intervention type: GENETIC
Group type: ACTIVE_COMPARATOR
Intervention: Saliva sample
Description: Buccal cell material will be sampled from all participants on day3
Study NCT01512316 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Functional neuroimaging (fMRI)
Study NCT01512316 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional neuroimaging (fMRI)
Study NCT06194162 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Weighted blanket
Description: The intervention group will receive a weighted blanket classified as a medical device class 1 as an add on to usual treatment. Participants will be asked to choose one out of at least three different weighted blankets, each with different weight classes. The choice of weighted blanket is solely taken by the participant after having tried all five blankets.~Adherence to the weighted blanket intervention is defined as reported use 60 % of the intervention period.~Usual treatment as part of standard care for children with ADHD, which can consist of sleep hygiene, psychoeducation, cognitive behavioral theory, medications such as melatonin or ADHD medication.
Study NCT06194162 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Non-weighted blanket
Description: The control comparator will receive a sham intervention in the form of a non-weighted blanket as an add on to usual care. Participants will be asked to choose one out of two different sham blankets.~Usual treatment as part of standard care for children with ADHD, which can consist of sleep hygiene, psychoeducation, cognitive behavioral theory, medications such as melatonin or ADHD medication.
Study NCT06165757 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: noise stimulation
Description: Apply non harmonic and white noise sound stimuli to the subjects, and then measure the threshold and tolerance values of pressure pain, cold pain, and electrical pain.
Study NCT04525794 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BRight DCB
Description: The BRight Drug-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon catheter (BRight DCB) is intended for dilatation of de novo lesions in native superficial femoral or popliteal arteries with a simultaneous release of drug to the vessel wall as a secondary action to reduce occurrence of a restenosis of the treated vessel segment.
Study NCT06380452 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5% Permethrin Creme
Description: At visit V0, the investigational cream is applied once topically to the whole body. For patients who are not cured at visit V1, i.e. 14 days later, the application is repeated analogously once at this time.
Study NCT06380452 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10% Permethrin Creme
Description: At visit V0, the investigational cream is applied once topically to the whole body. For patients who are not cured at visit V1, i.e. 14 days later, the application is repeated analogously once at this time.
Study NCT05950880 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity shoulder exercise
Description: Exercises that target the rotator cuff muscles using 90% of one repetition maximum only for 5 repetitions
Study NCT05950880 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: Conventional physical therapy consisting of scapular stabilization exercises, posterior capsule stretch, and rotator cuff activation exercises
Study NCT05950880 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy
Description: Conventional physical therapy consisting of scapular stabilization exercises, posterior capsule stretch, and rotator cuff activation exercises
Study NCT04761432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: neoGuard
Description: NeoGuard is a wireless wearable vital signs monitor that continuously measures temperature, pulse rate, respiratory rate and oxygen saturation.
Study NCT05231525 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WiTOF
Description: Data collection on the WiTOF monitor
Study NCT05231525 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TOFscan
Description: Data collection on the TOFscan monitor
Study NCT03553511 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vaginal vault suspension to the uterosacral ligaments
Description: Laparoscopic hysterectomy with vaginal vault suspension to the uterosacral ligaments
Study NCT03553511 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: McCall culdoplasty
Description: Vaginal hysterectomy with McCall culdoplasty
Study NCT04579432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: With the training module prepared according to the ADDIE model, the intervention group will be trained on reproductive health and sexual health.
Study NCT04900454 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DVX201
Description: Single infusion of DVX201, an allogeneic NK cell therapy derived from CD34+ hematopoietic stem cells
Study NCT06050070 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: FMRI with sham controlled feedback
Description: During the second fMRI, the study will introduce the real time fMRI neurofeedback part of the study. This is where subjects will use the activity from the brain to control the size of the circular pattern viewed in the first two visits. This is real time fMRI because the pattern will change, in real time, based on what the fMRI scan measures in the brain. Participants will be encouraged to make the circular pattern grow in size, just by thinking about it.~In order to see if the neurofeedback is really helping change the size of the circular pattern, the study team will have a control condition. In this controlled condition, subjects will see the circular pattern change, and the study team will ask participants to try and increase the size, except that the changing size will not actually be determined by your brain activity. This a called a sham condition because the feedback signal is not real.